News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,654 Results
Type
Article (40034)
Company Profile (271)
Press Release (660349)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (205080)
Career Advice (2020)
Deals (35529)
Drug Delivery (97)
Drug Development (81234)
Employer Resources (172)
FDA (16201)
Job Trends (14908)
News (346430)
Policy (32639)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49765)
ALS (86)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (122)
Approvals (16204)
Artificial intelligence (242)
Autoimmune disease (22)
Automation (15)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (105)
Biotechnology (190)
Bladder cancer (64)
Brain cancer (26)
Breast cancer (271)
Cancer (2141)
Cardiovascular disease (170)
Career advice (1686)
Career pathing (29)
CAR-T (146)
Cell therapy (410)
Cervical cancer (19)
Clinical research (66015)
Collaboration (817)
Compensation (518)
Complete response letters (19)
COVID-19 (2600)
CRISPR (38)
C-suite (231)
Cystic fibrosis (100)
Data (2083)
Decentralized trials (2)
Denatured (19)
Depression (41)
Diabetes (262)
Diagnostics (6375)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86516)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112529)
Executive appointments (711)
FDA (17408)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (735)
Gene editing (102)
Generative AI (19)
Gene therapy (286)
GLP-1 (706)
Government (4422)
Grass and pollen (4)
Guidances (51)
Healthcare (18832)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (114)
Indications (27)
Infectious disease (2741)
Inflammatory bowel disease (137)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (92)
Interviews (311)
IPO (16532)
IRA (42)
Job creations (3664)
Job search strategy (1434)
Kidney cancer (10)
Labor market (36)
Layoffs (467)
Leadership (16)
Legal (7943)
Liver cancer (72)
Lung cancer (307)
Lymphoma (145)
Machine learning (5)
Management (58)
Manufacturing (292)
MASH (63)
Medical device (13366)
Medtech (13371)
Mergers & acquisitions (19520)
Metabolic disorders (667)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1892)
NextGen: Class of 2025 (6548)
Non-profit (4488)
Northern California (2577)
Now hiring (38)
Obesity (358)
Opinion (208)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (226)
Patient recruitment (103)
Peanut (46)
People (57587)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20575)
Phase II (29075)
Phase III (21662)
Pipeline (1122)
Policy (135)
Postmarket research (2564)
Preclinical (8713)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (372)
Real estate (5952)
Recruiting (65)
Regulatory (22288)
Reports (46)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (129)
Series B (81)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2220)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3626)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (28)
The Weekly (29)
United States (22365)
Vaccines (672)
Venture capitalists (42)
Weight loss (232)
Women's health (34)
Worklife (15)
Date
Today (186)
Last 7 days (530)
Last 30 days (2455)
Last 365 days (32993)
2025 (9651)
2024 (35330)
2023 (40179)
2022 (51290)
2021 (55836)
2020 (54157)
2019 (46641)
2018 (35126)
2017 (32227)
2016 (31634)
2015 (37712)
2014 (31456)
2013 (26501)
2012 (28772)
2011 (29426)
2010 (27526)
Location
Africa (721)
Alabama (52)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (37999)
Australia (6227)
California (5894)
Canada (1959)
China (499)
Colorado (260)
Connecticut (265)
Delaware (137)
Europe (81596)
Florida (870)
Georgia (202)
Idaho (58)
Illinois (520)
India (26)
Indiana (305)
Iowa (10)
Japan (154)
Kansas (103)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (868)
Massachusetts (4402)
Michigan (216)
Minnesota (383)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1674)
New Mexico (28)
New York (1681)
North Carolina (946)
North Dakota (7)
Northern California (2577)
Ohio (201)
Oklahoma (14)
Oregon (34)
Pennsylvania (1322)
Puerto Rico (11)
Rhode Island (32)
South America (1099)
South Carolina (21)
South Dakota (1)
Southern California (2220)
Tennessee (100)
Texas (879)
Utah (173)
Virginia (140)
Washington D.C. (61)
Washington State (543)
West Virginia (3)
Wisconsin (51)
700,654 Results for "nielsen biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nielsen BioSciences Successfully Completes Enrollment into Phase 3 Trial of CANDIN for the Treatment of Common Warts
February 26, 2025
·
3 min read
Drug Development
Nielsen Biosciences Announces Enrollment of First Patient in Phase 3 Trial of CANDIN for the Treatment of Common Warts
Nielsen BioSciences, Inc. today announced the first patient enrolled in CFW-3A – a Phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of CANDIN ® for the treatment of Verruca vulgaris (common warts) in adolescents and adults.
March 5, 2024
·
3 min read
Business
Vial Partners with Nielsen BioSciences, Inc. in Phase III Clinical Trial for the Treatment of Common Warts
Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with Nielsen BioSciences, Inc. (Nielsen), a privately-held biopharmaceutical company based in San Diego, CA, to study the safety and efficacy of CANDIN® for the treatment of common warts.
June 14, 2023
·
5 min read
Business
Nielsen BioSciences, Inc. Enters into License Agreement with Maruho Co. Ltd. for the Treatment of Common Warts
Nielsen BioSciences, Inc. (“Nielsen”), a privately-held, San Diego-based biopharmaceutical company, today announced that it has entered into a license agreement with Maruho Co., Ltd. (“Maruho”), granting Maruho exclusive rights to market CANDINⓇ in Japan for the treatment of Verruca vulgaris (common warts).
May 16, 2023
·
5 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
1 of 70,066
Next
